Systematic Optimization for Production of the Anti-MRSA Antibiotics WAP-8294A in an Engineered Strain of Lysobacter Enzymogenes

Overview

Journal Microb Biotechnol

Specialties Biotechnology
Microbiology

Date 2019 Sep 15

PMID 31520522

Citations 5

Authors

Xusheng Chen

Shanren Li

Lingjun Yu

Amanda Miller

Liangcheng Du

Affiliations

Soon will be listed here.

Abstract

WAP-8294A is a group of cyclic lipodepsipeptides and considered as the first-in-class new chemical entity with potent activity against methicillin-resistant Staphylococcus aureus. One of the roadblocks in developing the WAP-8294A antibiotics is the very low yield in Lysobacter. Here, we carried out a systematic investigation of the nutritional and environmental conditions in an engineered L. enzymogenes strain for the optimal production of WAP-8294A. We developed an activity-based simple method for quick screening of various factors, which enabled us to optimize the culture conditions. With the method, we were able to improve the WAP-8294A yield by 10-fold in small-scale cultures and approximately 15-fold in scale-up fermentation. Additionally, we found the ratio of WAP-8294A2 to WAP-8294A1 in the strains could be manipulated through medium optimization. The development of a practical method for yield improvement in Lysobacter will facilitate the ongoing basic research and clinical studies to develop WAP-8294A into true therapeutics.

Citing Articles

Treatment of MRSA Infection: Where are We?.

Nazli A, Tao W, You H, He X, He Y Curr Med Chem. 2024; 31(28):4425-4460.

PMID: 38310393 DOI: 10.2174/0109298673249381231130111352.

Underexplored bacteria as reservoirs of novel antimicrobial lipopeptides.

Clements-Decker T, Kode M, Khan S, Khan W Front Chem. 2022; 10:1025979.

PMID: 36277345 PMC: 9581180. DOI: 10.3389/fchem.2022.1025979.

Characterisation of the Antibiotic Profile of AZ78, an Effective Biological Control Agent of Plant Pathogenic Microorganisms.

Brescia F, Vlassi A, Bejarano A, Seidl B, Marchetti-Deschmann M, Schuhmacher R Microorganisms. 2021; 9(6).

PMID: 34204563 PMC: 8235233. DOI: 10.3390/microorganisms9061320.

An intrinsic mechanism for coordinated production of the contact-dependent and contact-independent weapon systems in a soil bacterium.

Yang M, Ren S, Shen D, Yang N, Wang B, Han S PLoS Pathog. 2020; 16(10):e1008967.

PMID: 33035267 PMC: 7577485. DOI: 10.1371/journal.ppat.1008967.

Systematic optimization for production of the anti-MRSA antibiotics WAP-8294A in an engineered strain of Lysobacter enzymogenes.

Chen X, Li S, Yu L, Miller A, Du L Microb Biotechnol. 2019; 12(6):1430-1440.

PMID: 31520522 PMC: 6801147. DOI: 10.1111/1751-7915.13484.

References

Zhang W, Li Y, Qian G, Wang Y, Chen H, Li Y . Identification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11. Antimicrob Agents Chemother. 2011; 55(12):5581-9. PMC: 3232812. DOI: 10.1128/AAC.05370-11. View

Kato A, Hirata H, Ohashi Y, Fujii K, Mori K, Harada K . A new anti-MRSA antibiotic complex, WAP-8294A II. Structure characterization of minor components by ESI LCMS and MS/MS. J Antibiot (Tokyo). 2011; 64(5):373-9. DOI: 10.1038/ja.2011.9. View

Itoh H, Tokumoto K, Kaji T, Paudel A, Panthee S, Hamamoto H . Total Synthesis and Biological Mode of Action of WAP-8294A2: A Menaquinone-Targeting Antibiotic. J Org Chem. 2017; 83(13):6924-6935. DOI: 10.1021/acs.joc.7b02318. View

Falzone M, Crespo E, Jones K, Khan G, Korn V, Patel A . Nutritional control of antibiotic production by Streptomyces platensis MA7327: importance of l-aspartic acid. J Antibiot (Tokyo). 2017; 70(7):828-831. PMC: 5642980. DOI: 10.1038/ja.2017.49. View

Wang Y, Qian G, Liu F, Li Y, Shen Y, Du L . Facile method for site-specific gene integration in Lysobacter enzymogenes for yield improvement of the anti-MRSA antibiotics WAP-8294A and the antifungal antibiotic HSAF. ACS Synth Biol. 2013; 2(11):670-8. PMC: 3830728. DOI: 10.1021/sb4000806. View

Choo E, Chambers H . Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Infect Chemother. 2016; 48(4):267-273. PMC: 5204005. DOI: 10.3947/ic.2016.48.4.267. View

Wang Y, Zhao Y, Zhang J, Zhao Y, Shen Y, Su Z . Transcriptomic analysis reveals new regulatory roles of Clp signaling in secondary metabolite biosynthesis and surface motility in Lysobacter enzymogenes OH11. Appl Microbiol Biotechnol. 2014; 98(21):9009-20. PMC: 4207120. DOI: 10.1007/s00253-014-6072-1. View

Nigo M, Diaz L, Carvajal L, Tran T, Rios R, Panesso D . Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis. Antimicrob Agents Chemother. 2017; 61(3). PMC: 5328541. DOI: 10.1128/AAC.01235-16. View

Kato A, Nakaya S, Kokubo N, Aiba Y, Ohashi Y, Hirata H . A new anti-MRSA antibiotic complex, WAP-8294A. I. Taxonomy, isolation and biological activities. J Antibiot (Tokyo). 1999; 51(10):929-35. DOI: 10.7164/antibiotics.51.929. View

10.

Yu F, Zaleta-Rivera K, Zhu X, Huffman J, Millet J, Harris S . Structure and biosynthesis of heat-stable antifungal factor (HSAF), a broad-spectrum antimycotic with a novel mode of action. Antimicrob Agents Chemother. 2006; 51(1):64-72. PMC: 1797680. DOI: 10.1128/AAC.00931-06. View

11.

Delgado A, Brito D, Fevereiro P, Tenreiro R, Peres C . Bioactivity quantification of crude bacteriocin solutions. J Microbiol Methods. 2005; 62(1):121-4. DOI: 10.1016/j.mimet.2005.01.006. View

12.

Yu L, Su W, Fey P, Liu F, Du L . Yield Improvement of the Anti-MRSA Antibiotics WAP-8294A by CRISPR/dCas9 Combined with Refactoring Self-Protection Genes in Lysobacter enzymogenes OH11. ACS Synth Biol. 2017; 7(1):258-266. PMC: 5775038. DOI: 10.1021/acssynbio.7b00293. View

13.

Chen H, Olson A, Su W, Dussault P, Du L . Fatty Acyl Incorporation in the Biosynthesis of WAP-8294A, a Group of Potent Anti-MRSA Cyclic Lipodepsipeptides. RSC Adv. 2016; 5:105753-105759. PMC: 4695214. DOI: 10.1039/c5ra20784c. View

14.

Chen X, Li S, Yu L, Miller A, Du L . Systematic optimization for production of the anti-MRSA antibiotics WAP-8294A in an engineered strain of Lysobacter enzymogenes. Microb Biotechnol. 2019; 12(6):1430-1440. PMC: 6801147. DOI: 10.1111/1751-7915.13484. View

15.

Roch M, Gagetti P, Davis J, Ceriana P, Errecalde L, Corso A . Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost. Front Microbiol. 2017; 8:2303. PMC: 5723333. DOI: 10.3389/fmicb.2017.02303. View